Potentiation of Inhibition of Wild-Type and Mutant Human Immunodeficiency Virus Type 1 Reverse Transcriptases by Combinations of Nonnucleoside Inhibitors and d- and l-(β)-Dideoxynucleoside Triphosphate Analogs

Combinations of reverse transcriptase (RT) inhibitors are currently used in anti-human immunodeficiency virus therapy in order to prevent or delay the emergence of resistant virus and to improve the efficacy against viral enzymes carrying resistance mutations. Drug-drug interactions can result in ei...

ver descrição completa

Detalhes bibliográficos

Publicado no:	Antimicrob Agents Chemother
Principais autores:	Maga, Giovanni, Hübscher, Ulrich, Pregnolato, Massimo, Ubiali, Daniela, Gosselin, Gilles, Spadari, Silvio
Formato:	Artigo
Idioma:	Inglês
Publicado em:	American Society for Microbiology (ASM) 2001
Assuntos:	Antiviral Agents
Acesso em linha:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC90443/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/11257034/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/AAC.45.4.1192-1200.2001
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!